Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Chemical Intermediates > 17a-Hydroxyprogesterone Acetate CAS 302-23-8

17a-Hydroxyprogesterone Acetate CAS 302-23-8

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 302-23-8

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
302-23-8
Appearance::
White Powder
Molecular Formula::
C23H32O4
Molecular Weight::
372.49800
EINECS NO::
206-119-6
MDL NO::
MFCD00021156
CAS NO::
302-23-8
Appearance::
White Powder
Molecular Formula::
C23H32O4
Molecular Weight::
372.49800
EINECS NO::
206-119-6
MDL NO::
MFCD00021156
17a-Hydroxyprogesterone Acetate CAS 302-23-8

Product Description:

Product Name: 17a-Hydroxyprogesterone acetate CAS NO: 302-23-8

 

 

Synonyms:

17α-Acetoxyprogesterone;

ProgesteroneAcetate;

4-Pregnen-17α-ol-3,20-dione acetate;

 

 

Chemical & Physical Properties:

Appearance: White Powder

Assay :≥99.0%

Density: 1.14 g/cm3

Boiling Point: 490.2℃ at 760 mmHg

Melting Point: 249-250℃

Flash Point: 211.6℃

Refractive Index: 1.542

 

 

Safety Information:

RTECS: TU5074000

Safety Statements: S22; S24/25; S45

WGK Germany: 3

RIDADR: UN 2811 6

Risk Statement: R40

Hazard Code: Xn

 

 

Hydroxyprogesterone acetate (HPA) (INN) (brand name Prodox), or 17α-hydroxyprogesterone acetate (17-OHPA), also known as acetoxyprogesterone, is a synthetic, steroidal, orally-active progestin which was discovered by Upjohn in the 1950s and, in 1960, was marketed for use in veterinary medicine. It is a derivative of progesterone and the acetate ester of 17-hydroxyprogesterone, and is a parent compound of a number of progestins, including chlormadinone acetate, cyproterone acetate, medroxyprogesterone acetate, and megestrol acetate.

Hydroxyprogesterone acetate is of relatively low potency as a progestogen, which may explain its limited relative use. It is 100-fold less potent than medroxyprogesterone acetate, 400-fold less potent than chlormadinone acetate, and 1200-fold less potent than cyproterone acetate.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.